1-Chloroethyl Cyclohexyl Carbonatis CAS 99464-83-2 Puritas >99.0% (GC) Candesartan Cilexetil Intermedia Factor
Ruifu Chemical Supple Candesartan Cilexetil medium cum puritate
Candesartan Cilexetil CAS 145040-37-5
Candesartan CAS 139481-59-7
1-Chloroethyl Cyclohexyl Carbonatis CAS 99464-83-2
Candesartan Cilexetil Intermedia Eethyl Ester C6 CAS 139481-41-7
Candesartan Cilexetil Intermediate CAS 139481-44-0
Trityl Candesartan Cilexetil CAS 170791-09-0
Nomen chemicum | 1-Chloroethyl Cyclohexyl carbonatis |
Synonyma | Carbonic Acidum 1-Chloroethyl Cyclohexyl Ester |
CAS Number | 99464-83-2 |
CATTUS Number | RF-PI1888 |
Stock Status | In Stock, Productio Ascendite ad Tons |
Formulae hypotheticae | C9H15ClO3 |
M. Pondus | 206.67 |
Ferveret | 107℃/10 mmHg |
Brand | Ruifu Chemical |
Item | Specifications |
Aspectus | Hyalina ad ipsum deficiens Yellow Liquid |
Puritas / Analysis Methodus | >99.0% (GC) |
Index refractivus n20/D | 1.454~1.458 |
Gravitas Imprimis (20/20℃) | 1.26~1.131 |
Totalis immunditias | <1.00% |
1 H NMR Spectrum | Congruunt cum Structure |
Test Standard | Enterprise Standard |
Consuetudinem | Intermedia Candesartanae Cilexetil (CAS: 145040-37-5) |
sarcina: Fluorinated Utrem, 25kg/Drum, vel secundum exigentiam mos
Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine et humore
1-Chloroethyl Cyclohexyl Carbonatis (CAS: 99464-83-2) adhibetur in synthesi Candesartanae Cilexetil (CAS: 145040-37-5).Candesartan Cilexetil est receptator angiotensin obstructor (ARB), receptor angiotensin obstructores efficaciter defendat contra effectus nocivos systematis renin-angiotensin-aldosteronis quae cum hypertensione vel diabete occurrunt.Candesartan Cilexetil soli adhiberi potest vel cum aliis agentibus hypertensionem tractantibus.Dissimile angiotensin-convertentis enzyme (ACE) inhibitores, ARBs tussim aridae effectum adversam non habent.Candesartan Cilexetil tractari potest hypertensionem, hypertensionem solitarium, hypertrophium ventriculi sinistrum et nephropathiam diabeticam.Potest etiam adhiberi ut jocus agentis ad defectum cordis curationem, dysfunctionem systolicam, infarctum myocardialem et arteriam coronariam.